ELISA to be Highly Preferred Technique in Viral Antigens Market Through 2025
The advent of advanced therapies and test kits that employ the use of virus components such as antigens has paved way for the treatment several diseases. In recent years, the viral antigens market has been witnessing substantial investments, robust R&D activities and strategic collaborations. In 2018, ACROBiosystems announces collaboration with ProMab Biotechnologies for immunotherapy research using viral antigens for vaccine development and launch of new diagnostic kits.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1305
Acquisition of smaller companies to expand their geographical presence is also one of the key trends followed by leading manufactures in the viral antigens market. Besides, increasing government initiatives to spread awareness related to various viral diseases are boosting the sales of viral antigen products.
The global viral antigens market was valued at US$ 134.2 Bn in 2019, and is projected to witness strong growth during the forecast period (2020- 2030).
Key Takeaways of Viral Antigens Market Study
- A large number of companies manufacturing viral antigen products, especially influenza and hepatitis virus antigens, contributed significantly to the market growth.
- North America and Europe collectively hold over 70% of the global viral antigens market value, owing to rapid launch of new products and significant advance in biopharmaceutical research in these regions.
- In terms of end user, research institutes are expected to dominate the viral antigens market during the forecast period.
- The viral antigens market is highly consolidated. Some of the prominent manufacturers include Bio Rad Laboratories, Viral Antigens, Inc. (Meridian), Microbix Biosystems Inc. and few others.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1305
“Use of viral antigens for developing COVID-19 antibody detection kits has significantly led to a demand spurt. Growing efforts to counter the rising cases of coronavirus are thus expected to increase the sales of viral antigens,” says the Fact.MR analyst.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/1305
Key Segments of Viral Antigens Market
Fact.MR’s study on the viral antigens market offers information divided into three important segments—component, technique,end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Increasing Consolidation among Key Players and Technology Advancements
The viral antigens market is expanding due to growing incidence of acute diseases such as cancers, hepatitis, AIDS, & infectious diseases and increasing need for early diagnosis. Key players in the market are channelizing efforts to increase flexibility, productivity, and throughput capabilities and redefine control productivity.
The viral antigens market shows a high level of consolidation. Collaborations, research and development initiatives, new service launches, and mergers & acquisitions among global and regional players are characteristic of the overall competition in the global viral antigens market.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
The post ELISA to be Highly Preferred Technique in Viral Antigens Market Through 2025 appeared first on Latest Market Reports.